PUBLISHER: The Business Research Company | PRODUCT CODE: 1127688
PUBLISHER: The Business Research Company | PRODUCT CODE: 1127688
“Diagnostic Equipment Global Market Report 2022 ” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global Diagnostic Equipment market.
This report focuses on Diagnostic Equipment market which is experiencing strong growth. The report gives a guide to the Diagnostic Equipment market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
Where is the largest and fastest growing market for the Diagnostic Equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Machinery Manufacturing market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider Diagnostic Equipment market, and compares it with other markets.
1) By Type:X-Ray Systems; Ultrasound Systems; Computed Tomography (CT) Scanners; Magnetic Resonance Imaging Systems; Cardiovascular Monitoring And Diagnostic Devices; Nuclear Imaging Device.
2) By Mobility: Stationary; Mobile
3) By End User: Hospitals; Diagnostic imaging centres
Companies Mentioned: Philips Healthcare; Hitachi Medical Systems; Fujifilm Holdings; Siemens Healthcare; GE Healthcare.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Major players in the diagnostic equipment market include: Philips Healthcare, Hitachi Medical Systems, Fujifilm Holdings, Siemens Healthcare, and GE Healthcare.
The global diagnostic equipment market is expected to grow from $43.81 billion in 2021 to $47.74 billion in 2022 at a compound annual growth rate (CAGR) of 9.0%. The diagnostic equipment market is expected to grow to $59.46 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%.
The diagnostic devices (or) equipment market consists of sales of diagnostic equipment and related services by entities (organizations, sole traders, and partnerships) that are used to identify the nature or cause of a certain phenomenon, usually related to a medical condition. Some of the devices include magnetic resonance imaging apparatuses, temperature sensors or pacemakers.
The main types of diagnostic devices or equipment are x-rayed systems, ultrasound systems, computed tomography (ct) scanners, magnetic resonance imaging systems, cardiovascular monitoring and diagnostic devices, and nuclear imaging device. X-rays refer to a type of electromagnetic radiation, just like visible light. The mobility is stationary, and mobile and is used in hospitals, and diagnostic imaging centers.
The regions covered in diagnostic devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
An increase in the geriatric population is expected to propel the growth of the diagnostic devices market going forward. Older people are likely to suffer from diseases such as diabetes, cancer, and arthritis among others, which would increase the demand for diagnostic devices. For instance, in 2020, according to the United Nations, a US-based intergovernmental organization, there are approximately 727 million persons are aged 65 years and above worldwide, and expected to reach approximately 1.5 billion persons by 2050. Therefore, the increase in the geriatric population is driving the growth of the diagnostic devices market.
The emergence of routine diagnostic kits is a key trend gaining popularity in the diagnostic devices market. Companies operating in the market are focusing on developing diagnostic kits to gain market coverage. For instance, in March 2022, Mylab Discovery Solutions, an India-based healthcare company is set to launch an entire range of routine diagnostic kits and devices in conventional and point-of-care formats. Immunology, Biochemistry, and Haematology are the three main market sub-segments represented by the devices and kits included in them.
In July 201, DiaSorin S.p.A., an Italy-based biotechnology company acquired Luminex Corporation for a deal amount of $1.8 billion. Through the acquisition, DiaSorin would gain access to Luminex's multiplexing technology and a portfolio that would strengthen its existing offering, while expanding the Group presence in the United States. Further, this agreement would give the Life Science sector access to Luminex's applications, promoting academic and scientific research, improving collaboration with biopharma businesses, and boosting access to clinical multiplexing assays for upcoming Value-Based Care initiatives. Luminex Corporation is a US-based biotechnology company that manufactures medical diagnostic devices.
The countries covered in the diagnostic devices or equipment market are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.